<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="10584">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02969174</url>
  </required_header>
  <id_info>
    <org_study_id>ShangjiTongjiHsxk</org_study_id>
    <nct_id>NCT02969174</nct_id>
  </id_info>
  <brief_title>Establish a Non-invasive Prenatal Genotyping and Extraction Technology to Diagnose and Treat the HDN.</brief_title>
  <official_title>Clinical Professor of Shanghai Tongji Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai Tongji Hospital, Tongji University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai Tongji Hospital, Tongji University School of Medicine</source>
  <brief_summary>
    <textblock>
      To establish a genotyping and extraction technology of non invasive prenatal diagnosis for
      fetal blood group genotype from cell-free fetal DNA in peripheral blood of pregnant women.

      To achieve prenatal accurate identification of fetal blood group genotypesï¼Œand provide
      credible theoretical evidence for the prenatal diagnosis and treatment of hemolytic disease
      of newborn (HDN).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Establish a Non-invasive Prenatal Genotyping and Extraction Technology to Diagnose and Treat
      the HDN.
    </textblock>
  </detailed_description>
  <overall_status>Approved for marketing</overall_status>
  <phase>N/A</phase>
  <study_type>Expanded Access</study_type>
  <has_expanded_access>No</has_expanded_access>
  <condition>HDFN</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>zimin Lu,Guo Sa</intervention_name>
    <description>chengzhong Liu</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        blood samples of pregnant couples,gender/nation/region is unlimited.

        Exclusion Criteria:

        adipose or hemolytic samples,overdue samples,unidentified samples
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Weeks</minimum_age>
    <maximum_age>38 Weeks</maximum_age>
  </eligibility>
  <verification_date>November 2016</verification_date>
  <lastchanged_date>November 17, 2016</lastchanged_date>
  <firstreceived_date>November 3, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai Tongji Hospital, Tongji University School of Medicine</investigator_affiliation>
    <investigator_full_name>Liming Cheng</investigator_full_name>
    <investigator_title>The President of Shanghai Tongji Hospital</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
